Vera Therapeutics Q3 Revenue Tops Estimates by $6.88 Million

The company posted $10.2 million in revenue, while its GAAP loss was $1.30 per share, 32 cents narrower than estimates.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.